Butterfly Network, Inc. (NYSE: BFLY) is a medical technology company that completed its business combination with a special purpose acquisition company in early 2021, with an amended Form 8-K/A filed with the SEC on February 16, 2021 reflecting details tied to the closing of that transaction. Founded by Jonathan Rothberg, the Connecticut-based company develops and commercializes handheld, whole-body ultrasound devices powered by semiconductor chip technology, operating in the medical imaging and digital health sector. BFLY has traded on the New York Stock Exchange since its SPAC-driven debut in 2021. For comprehensive filing history, deal terms, and ongoing disclosure data on Butterfly Network and hundreds of other SPAC transactions, sign up for full access at SpacDesk.